Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 2:58 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 28 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Atralin gel Clear all

Conditions: Acne Vulgaris
Interventions: Tretinoin Facial Gel, Adapalene/Benzoyl Peroxide Facial Gel; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 162 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Broomall, Pennsylvania

Conditions: Acne Vulgaris
Interventions: Tretinoin gel, Adapalene and Benzoyl peroxide; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Broomall, Pennsylvania

Conditions: Acne Vulgaris, Acne
Interventions: CT Gel, Clindamycin Gel (clindamycin ), Tretinoin Gel (tretinoin), Vehicle Gel; Drug
Lead sponsor: Stiefel, a GSK Company; Industry
Eligibility: 12 Years and older
Enrollment: 1,649 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 27
States / cities: Birmingham, Alabama • Mobile, Alabama • Hot Springs, Arkansas + 24 more

Conditions: Acne Vulgaris
Interventions: Dapsone; Tretinoin, Tretinoin; Drug
Lead sponsor: Allergan; Industry
Eligibility: 12 Years and older
Enrollment: 163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Strongsville, Ohio

Conditions: Photoaging
Interventions: adapalene gel, 0.3%, tretinoin 0.05% emollient cream; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 40 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Acne
Interventions: Duac, Ziana gel; Drug
Lead sponsor: Stiefel, a GSK Company; Industry
Eligibility: 12 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 2
States / cities: Louisville, Kentucky • Mason, Ohio

Conditions: Acne Vulgaris
Interventions: clindamycin phosphate 1.2% and tretinoin 0.025%, clindamycin 1% gel, tretinoin 0.025% cream; Drug
Lead sponsor: Wake Forest University; Other
Eligibility: 12 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Healthy
Interventions: Atralin (tretinoin) Gel, 0.05%; Drug
Lead sponsor: Coria Laboratories, Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Acne
Interventions: Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel; Drug
Lead sponsor: Callender Center for Clinical Research; Other
Eligibility: 12 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Mitchellville, Maryland • Philadelphia, Pennsylvania

Conditions: Acne Vulgaris
Interventions: Epiduo Gel, Retin-A Micro Microsphere 0.1%; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Acne Vulgaris
Interventions: Tretinoin Gel Microsphere, 0.04%, RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.04%, Placebo Control; Drug
Lead sponsor: Sun Pharmaceutical Industries, Inc.; Industry
Eligibility: 12 Years to 40 Years
Enrollment: 1,043 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Hawthorne, New York

Conditions: Acne
Interventions: Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide; Drug
Lead sponsor: Medicis Global Service Corporation; Industry
Eligibility: 12 Years to 30 Years
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 10
States / cities: Birmingham, Alabama • Santa Monica, California • Hockessin, Delaware + 7 more

Conditions: Acne, Healthy
Interventions: Altreno, Benzoyl peroxide; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 40 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acne Vulgaris
Interventions: Tretinoin Gel Microsphere, 0.1%, RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1%, Placebo Control; Drug
Lead sponsor: Sun Pharmaceutical Industries, Inc.; Industry
Eligibility: 12 Years to 40 Years
Enrollment: 973 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Acne
Interventions: Tretinoin microsphere 0.1%, Brand Retin-A Micro tretinoin microsphere gel 0.1%, placebo microsphere gel; Drug
Lead sponsor: Spear Pharmaceuticals; Industry
Eligibility: 12 Years to 40 Years
Enrollment: 480 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Land O' Lakes, Florida

Conditions: Rosacea
Interventions: tretinoin gel 0.05%, vehicle; Drug
Lead sponsor: Coria Laboratories, Ltd.; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Conshohocken, Pennsylvania

Conditions: Acne Vulgaris
Interventions: Dapsone plus Tretinoin Gel, Tretinoin Gel; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Broomall, Pennsylvania

Conditions: Acne Vulgaris
Interventions: Retin-A Micro 0.04% facial acne treatment, Vehicle control; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 9 Years to 11 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 12
States / cities: Encino, California • San Diego, California • Miami, Florida + 9 more

Conditions: Acne Vulgaris
Interventions: benzoyl peroxide wash, Tretinoin gel; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 247 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 12
States / cities: Boca Raton, Florida • Miami, Florida • Snellville, Georgia + 9 more

Conditions: Rosacea
Interventions: Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel, Placebo gel; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Stanford, California • Boston, Massachusetts

Conditions: Acne Vulgaris
Interventions: CTGel/ BPO Wash, Soap Free Cleanser and CTGel; Drug
Lead sponsor: Stiefel, a GSK Company; Industry
Eligibility: 12 Years to 45 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 5
States / cities: Coral Gables, Florida • Warren, Michigan • High Point, North Carolina + 2 more

Conditions: Acne Vulgaris
Interventions: clindamycin phosphate 1.2%/tretinoin 0.025% gel alone, clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths; Drug
Lead sponsor: Zeichner, Joshua, M.D.; Individual
Eligibility: 12 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Acne Vulgaris
Interventions: Adapalene Gel, Tretinoin Gel; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Broomall, Pennsylvania

Conditions: Rosacea
Interventions: vehicle gel, Atralin gel; Drug
Lead sponsor: Lisa E. Maier; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Search by objective public record fields.

Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face

Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face

A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel

Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris

Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage

Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne

Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris

Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

Efficacy & Safety of Clindamycin and Tretinoin in Acne

Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel

A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris

Combination Treatment for Moderate to Severe Acne

Profiling the Skin Microbiome in Response to Altreno in Acne Patients

A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris

Bioequivalence Study of Generic Tretinoin 0.1% Microsphere Gel, 0.1% Retin-A Micro® and Placebo

A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products

A Study of Acne Treatment in Children Ages 9 to 11

A Study of Different Use Regimens Using Two Acne Treatments

Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea

A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash

A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne

Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.

Atralin Gel for the Treatment of Rosacea